DE69927512D1 - Verwendung von op-1 zur herstellung einer pharmazeutischen zusammensetzung zur reparatur von nicht-gelenksknorpeldefekten eines säugers - Google Patents

Verwendung von op-1 zur herstellung einer pharmazeutischen zusammensetzung zur reparatur von nicht-gelenksknorpeldefekten eines säugers

Info

Publication number
DE69927512D1
DE69927512D1 DE69927512T DE69927512T DE69927512D1 DE 69927512 D1 DE69927512 D1 DE 69927512D1 DE 69927512 T DE69927512 T DE 69927512T DE 69927512 T DE69927512 T DE 69927512T DE 69927512 D1 DE69927512 D1 DE 69927512D1
Authority
DE
Germany
Prior art keywords
animals
repair
manufacture
pharmaceutical composition
tissues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69927512T
Other languages
English (en)
Other versions
DE69927512T2 (de
Inventor
Slobodan Vukicevic
Vladimir Katic
T Sampath
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stryker Corp
Original Assignee
Stryker Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stryker Corp filed Critical Stryker Corp
Application granted granted Critical
Publication of DE69927512D1 publication Critical patent/DE69927512D1/de
Publication of DE69927512T2 publication Critical patent/DE69927512T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51—Lyases (4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69927512T 1998-10-06 1999-07-30 Verwendung von op-1 zur herstellung einer pharmazeutischen zusammensetzung zur reparatur von nicht-gelenksknorpeldefekten eines säugers Expired - Lifetime DE69927512T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10316198P 1998-10-06 1998-10-06
US103161P 1998-10-06
PCT/US1999/017222 WO2000020021A1 (en) 1998-10-06 1999-07-30 Repair of larynx, trachea, and other fibrocartilaginous tissues

Publications (2)

Publication Number Publication Date
DE69927512D1 true DE69927512D1 (de) 2006-02-09
DE69927512T2 DE69927512T2 (de) 2006-07-06

Family

ID=22293705

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69927512T Expired - Lifetime DE69927512T2 (de) 1998-10-06 1999-07-30 Verwendung von op-1 zur herstellung einer pharmazeutischen zusammensetzung zur reparatur von nicht-gelenksknorpeldefekten eines säugers
DE69933686T Expired - Lifetime DE69933686T2 (de) 1998-10-06 1999-07-30 Zusammensetzung zur verwendung in der chemonukleolyse

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69933686T Expired - Lifetime DE69933686T2 (de) 1998-10-06 1999-07-30 Zusammensetzung zur verwendung in der chemonukleolyse

Country Status (10)

Country Link
US (2) US20020106362A1 (de)
EP (3) EP1117422B1 (de)
JP (5) JP4768125B2 (de)
AT (2) ATE305310T1 (de)
AU (3) AU770725B2 (de)
CA (2) CA2346375C (de)
DE (2) DE69927512T2 (de)
ES (2) ES2478257T3 (de)
MX (1) MXPA01003538A (de)
WO (2) WO2000020559A1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8632590B2 (en) 1999-10-20 2014-01-21 Anulex Technologies, Inc. Apparatus and methods for the treatment of the intervertebral disc
US7615076B2 (en) 1999-10-20 2009-11-10 Anulex Technologies, Inc. Method and apparatus for the treatment of the intervertebral disc annulus
US7004970B2 (en) 1999-10-20 2006-02-28 Anulex Technologies, Inc. Methods and devices for spinal disc annulus reconstruction and repair
US20030153976A1 (en) 1999-10-20 2003-08-14 Cauthen Joseph C. Spinal disc annulus reconstruction method and spinal disc annulus stent
US6592625B2 (en) 1999-10-20 2003-07-15 Anulex Technologies, Inc. Spinal disc annulus reconstruction method and spinal disc annulus stent
US20020032155A1 (en) * 2000-06-30 2002-03-14 Ferree Bret A. Method of treating disc herniation and disc degeneration with concentrated growth and differentiation factors
JPWO2003000287A1 (ja) * 2001-06-26 2004-10-07 小森 博達 ヘルニア治療剤
KR20040021697A (ko) 2001-08-13 2004-03-10 유니버시티 오브 플로리다 리서치 파운데이션, 인크. 신경 조직 복구를 증진시키는 물질 및 방법
GB0205022D0 (en) * 2002-03-04 2002-04-17 Univ Cambridge Tech Materials and methods for the treatment of cns damage
US6812211B2 (en) 2002-03-19 2004-11-02 Michael Andrew Slivka Method for nonsurgical treatment of the intervertebral disc and kit therefor
EP2301564A1 (de) 2002-05-04 2011-03-30 Acorda Therapeutics, Inc. Zusammensetzungen und verfahren zur förderung des neuronalen wachstums
ES2366333T3 (es) * 2002-08-15 2011-10-19 Acorda Therapeutics, Inc. Proteína quimérica.
US7959914B2 (en) * 2003-05-16 2011-06-14 Acorda Therapeutics, Inc. Methods of reducing extravasation of inflammatory cells
EP2353606B1 (de) * 2003-05-16 2013-04-17 Acorda Therapeutics, Inc. Zusammensetzungen und Verfahren zur Behandlung von ZNS-Schäden
MX348062B (es) 2003-05-16 2017-05-26 Acorda Therapeutics Inc Mutantes que degradan proteoglicanos para tratamiento del snc.
US7169405B2 (en) * 2003-08-06 2007-01-30 Warsaw Orthopedic, Inc. Methods and devices for the treatment of intervertebral discs
ES2411504T3 (es) * 2004-05-18 2013-07-05 Acorda Therapeutics, Inc. Métodos de purificación de condroitinasa y formulaciones estables de la misma
AU2011265308B2 (en) * 2004-05-25 2014-06-26 Stryker Corporation Use of Morphogenic Proteins for Treating Cartilage Defects
EP1763362B1 (de) * 2004-05-25 2011-07-06 Stryker Corporation Verwendung von op-1 zur behandlung von knorpeldefekten
US20060194726A1 (en) * 2004-05-25 2006-08-31 Rueger David C Methods of treating cartilage defects
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
FR2884437B1 (fr) 2005-04-19 2007-07-20 Commissariat Energie Atomique Dispositif et procede microfluidique de transfert de matiere entre deux phases immiscibles.
JP4907908B2 (ja) * 2005-06-29 2012-04-04 ルネサスエレクトロニクス株式会社 駆動回路及び表示装置
US7485295B2 (en) 2005-09-26 2009-02-03 Acorda Therapeutics, Inc. Compositions and methods of using chondroitinase ABCI mutants
JP4599563B2 (ja) * 2005-11-04 2010-12-15 国立大学法人 岡山大学 外耳道再建用成形品及びその製造方法
US20070213718A1 (en) * 2006-02-14 2007-09-13 Sdgi Holdings, Inc. Treatment of the vertebral column
US20070213717A1 (en) * 2006-02-14 2007-09-13 Sdgi Holdings, Inc. Biological fusion in the vertebral column
US20070227547A1 (en) * 2006-02-14 2007-10-04 Sdgi Holdings, Inc. Treatment of the vertebral column
US7520888B2 (en) * 2006-02-14 2009-04-21 Warsaw Orthopedic, Inc. Treatment of the vertebral column
US20070258941A1 (en) * 2006-05-02 2007-11-08 Pfister Brian E Methods and compositions for remediation of disc herniation by modifying structure
US20080027554A1 (en) * 2006-07-31 2008-01-31 Talmadge Karen D Kit and methods of treatment of an intervertebral disc
CA2666536C (en) 2006-10-10 2018-08-07 Acorda Therapeutics, Inc. Compositions and methods of using chondroitinase abci mutants
US20090286289A1 (en) * 2008-03-10 2009-11-19 Pang Danny Z Production of Hyaluronate Unsaturated Disaccharides and its Application
AU2009266947A1 (en) * 2008-07-04 2010-01-07 Axial Biotech, Inc Genetic markers associated with degenerative disc disease and uses thereof
US8163022B2 (en) 2008-10-14 2012-04-24 Anulex Technologies, Inc. Method and apparatus for the treatment of the intervertebral disc annulus
US20120122791A1 (en) * 2009-05-01 2012-05-17 Jnc Corporation Substrate for cartilage cultivation using artificial collagen, and method for cartilage regeneration treatment using the substrate
CN107412864A (zh) 2009-12-13 2017-12-01 阿米特·普拉卡什·戈维 生物活性移植物和复合物
US8652153B2 (en) 2010-01-11 2014-02-18 Anulex Technologies, Inc. Intervertebral disc annulus repair system and bone anchor delivery tool
WO2012058267A2 (en) * 2010-10-26 2012-05-03 Kyphon Sarl Devices containing a chemonucleolysis agent and methods for treating an intervertebral disc or spinal arachnoiditis
US8740982B2 (en) * 2010-10-26 2014-06-03 Kyphon Sarl Devices containing a chemonucleolysis agent and methods for treating an intervertebral disc or spinal arachnoiditis
US8404268B2 (en) 2010-10-26 2013-03-26 Kyphon Sarl Locally targeted anti-fibrotic agents and methods of use
US9414930B2 (en) 2010-10-26 2016-08-16 Kyphon SÀRL Activatable devices containing a chemonucleolysis agent
CN103260636A (zh) * 2010-12-13 2013-08-21 生化学工业株式会社 椎间盘突出治疗剂
US8460381B2 (en) 2011-03-31 2013-06-11 Warsaw Orthopedic, Inc. Methods and devices for the treatment of intervertebral discs disorders
US9737294B2 (en) 2013-01-28 2017-08-22 Cartiva, Inc. Method and system for orthopedic repair
EP2948068A4 (de) 2013-01-28 2016-09-28 Cartiva Inc Systeme und verfahren für orthopädischen reparaturen
US10493247B2 (en) 2016-03-15 2019-12-03 Medtronic Holding Company Sàrl Devices for delivering a chemical denervation agent and methods of use
CN113388599B (zh) * 2021-04-22 2022-10-28 浙江大学 用于分散生物组织的酶试剂盒和使用其获得单细胞悬液的方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4696816A (en) * 1985-11-07 1987-09-29 Brown Mark D Method for treating intervertebral disc displacement with enzymes
IL83003A (en) 1986-07-01 1995-07-31 Genetics Inst Factors that soak bone formation
US5013649A (en) 1986-07-01 1991-05-07 Genetics Institute, Inc. DNA sequences encoding osteoinductive products
US4968590A (en) 1988-04-08 1990-11-06 Stryker Corporation Osteogenic proteins and polypeptides
US5266683A (en) 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
US5011691A (en) 1988-08-15 1991-04-30 Stryker Corporation Osteogenic devices
US5284756A (en) 1988-10-11 1994-02-08 Lynn Grinna Heterodimeric osteogenic factor
EP0429570B1 (de) 1989-03-28 1998-01-14 Genetics Institute, Inc. Osteoinduktive zusammensetzungen
US5158934A (en) * 1989-09-01 1992-10-27 Genentech, Inc. Method of inducing bone growth using TGF-β
ATE209251T1 (de) 1990-05-16 2001-12-15 Genetics Inst Knochen- und knorpel-bildung hervorrufende proteine
CA2071912C (en) * 1990-11-30 2002-10-15 Hanne Bentz Use of a bone morphogenetic protein in synergistic combination with tgf-beta for bone repair
US5206023A (en) * 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
US5650276A (en) * 1991-03-11 1997-07-22 Creative Biomolecules, Inc. Morphogenic protein screening method
EP0612348B1 (de) 1991-11-04 2003-04-23 Genetics Institute, LLC Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung
US5385887A (en) * 1993-09-10 1995-01-31 Genetics Institute, Inc. Formulations for delivery of osteogenic proteins
ES2255059T3 (es) * 1993-12-07 2006-06-16 Genetics Institute, Llc Bmp-12, bmp-13 y composiciones suyas inductoras de tendon.
US5723331A (en) 1994-05-05 1998-03-03 Genzyme Corporation Methods and compositions for the repair of articular cartilage defects in mammals
US5906827A (en) * 1994-06-03 1999-05-25 Creative Biomolecules, Inc. Matrix for the manufacture of autogenous replacement body parts
AU1120295A (en) * 1994-11-07 1996-05-31 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Cartilage-derived morphogenetic proteins
US5902785A (en) * 1995-06-06 1999-05-11 Genetics Institute, Inc. Cartilage induction by bone morphogenetic proteins
US5674292A (en) * 1995-06-07 1997-10-07 Stryker Corporation Terminally sterilized osteogenic devices and preparation thereof
WO1998031788A1 (en) * 1997-01-21 1998-07-23 Genetics Institute, Inc. Injectable formulations for treatment of osteoporotic bone
US7041641B2 (en) * 1997-03-20 2006-05-09 Stryker Corporation Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
EP0900569B1 (de) 1997-08-22 2002-10-02 Seikagaku Corporation Arzneimittel zur Behandlung von durch Hernie gestörter intervertebraler Bandscheibe
US6080579A (en) 1997-11-26 2000-06-27 Charlotte-Mecklenburg Hospital Authority Method for producing human intervertebral disc cells

Also Published As

Publication number Publication date
JP2002526167A (ja) 2002-08-20
ATE305310T1 (de) 2005-10-15
CA2346375A1 (en) 2000-04-13
MXPA01003538A (es) 2005-09-08
EP1119611B1 (de) 2006-10-18
EP2374870A2 (de) 2011-10-12
AU2004202345B2 (en) 2007-12-13
EP1117422A1 (de) 2001-07-25
EP2374870B1 (de) 2014-04-23
US7132098B2 (en) 2006-11-07
ES2389555T3 (es) 2012-10-29
JP4620868B2 (ja) 2011-01-26
AU2004202345A1 (en) 2004-06-24
DE69933686D1 (de) 2006-11-30
DE69927512T2 (de) 2006-07-06
EP1119611A4 (de) 2004-12-01
EP1119611A1 (de) 2001-08-01
JP2015126921A (ja) 2015-07-09
WO2000020559A1 (en) 2000-04-13
AU772479B2 (en) 2004-04-29
CA2343698C (en) 2014-05-20
JP2013075173A (ja) 2013-04-25
US20040033221A1 (en) 2004-02-19
EP1117422B1 (de) 2005-09-28
ATE342961T1 (de) 2006-11-15
WO2000020021A1 (en) 2000-04-13
ES2478257T3 (es) 2014-07-21
AU5241799A (en) 2000-04-26
DE69933686T2 (de) 2007-08-23
CA2346375C (en) 2013-04-23
JP2002526553A (ja) 2002-08-20
EP2374870A3 (de) 2012-03-14
JP2010137085A (ja) 2010-06-24
AU5330199A (en) 2000-04-26
JP4768125B2 (ja) 2011-09-07
AU770725B2 (en) 2004-02-26
US20020106362A1 (en) 2002-08-08
JP5623764B2 (ja) 2014-11-12
CA2343698A1 (en) 2000-04-13

Similar Documents

Publication Publication Date Title
DE69927512D1 (de) Verwendung von op-1 zur herstellung einer pharmazeutischen zusammensetzung zur reparatur von nicht-gelenksknorpeldefekten eines säugers
DE60007079D1 (de) Methoden und zusammensetzungen zur heilung und reparatur von gelenkknorpeln
DE69528058T2 (de) Bmp-9 zusammensetzungen
KR960703615A (ko) 인간 골 형태발생 단백질을 사용한 신경 재생법(neural regeneration using human bone morphogenetic proteins)
DE69708517D1 (de) Kehlkopf-Endoprothese
SE9303977D0 (sv) Verfahren zur herstellung von implantatkeramikmaterial, insbesonders von hydroxylapatit aufweisenden implantatkeramikmaterial
BR9711967A (pt) Processos para o tratamento eficaz de cartilagem de superfìcie de junta articulante e para o transplante de condrócitos em uma matriz adequada, kit para transplante de condrócitos e para a prática dos processos, e, instrumento cirúrgico.
ATE226097T1 (de) Biomaterial für knochenersatz
EP1690874A3 (de) BMP-12, BMP-13 und diese enthaltende Sehnen-induzierende Zusammensetzungen
DK0884052T3 (da) Brusk/knogle-inducerende materialer til reparation
ATE255920T1 (de) Methoden und zusammensetzungen zur heilung und reparatur von gelenkknorpeln
Warnke et al. Tissue engineering of periosteal cell membranes in vitro
Guizzardi et al. Qualitative assessment of natural apatite in vitro and in vivo
Von Rechenberg et al. The use of photooxidized, mushroom-structured osteochondral grafts for cartilage resurfacing–a comparison to photooxidized cylindrical grafts in an experimental study in sheep
DE60017159D1 (de) In vivo assay zur prüfung der phänotypischen stabilität
EP1254670A1 (de) Typ II-Kollagenmatrizen für die Knorpelregeneration
Kim et al. The Effects of Air Exposure on Articular Cartilage; Degeneration & Regeneration

Legal Events

Date Code Title Description
8364 No opposition during term of opposition